Viewing StudyNCT00349349



Ignite Creation Date: 2024-05-05 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00349349
Status: COMPLETED
Last Update Posted: 2014-06-04
First Post: 2006-07-06

Brief Title: HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia B-CLL Patients Failing Fludarabine and Alemtuzumab
Sponsor:
Organization: GlaxoSmithKline